The 86th API China Autumn Exhibition concluded successfully. CHU PHARMA showcased its full range of APIs and injectable drug manufacturing solutions. During the exhibition, it signed annual supply framework agreements with leading pharmaceutical trading companies in Algeria and Tunisia, agreeing to a stable annual purchase volume of APIs exceeding ten million yuan. This signifies that the company's large-scale export capabilities have been formally recognized by major overseas clients.